New injection makes fat cells self-destruct
An experimental drug called CBL-514 has shown success in clinical trials by triggering the self-destruction of fat cells. Researchers believe this could provide a new treatment for obesity and help patients maintain weight loss after stopping other medications.
Why it matters
As obesity rates rise, this novel approach offers a potential alternative or supplement to current GLP-1 weight loss drugs, targeting fat cells directly through apoptosis.
An experimental injection that causes fat cells to destroy themselves has shown promising results in early human trials, significantly reducing dangerous fat hidden deep inside the abdomen. Researchers believe the treatment could eventually offer a new way to combat obesity and potentially help people maintain weight loss after stopping popular weight loss medications.
The drug, known as CBL-514, was highlighted at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy. Research indicates that it can reduce both subcutaneous fat, which sits directly beneath the skin, and visceral fat, which surrounds internal organs.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in